Expert Radar
Dr. Zev Wainberg, MD
Professor, David Geffen School of Medicine at UCLA
Doctor of Medicine, Tel Aviv University Faculty of Medicine
Dr. Zev A. Wainberg has 15 years of experience in the field of Medical Oncology. He earned his MD from Sackler School of Medicine, Tel Aviv University. After completing his internship and residency in Internal Medicine at Montefiore Medical Center, he went on to complete a prestigious fellowship in Hematology and Medical Oncology at UCLA Medical Center. Today, this expert is board certified in Medical Oncology. Formerly, he served as an Assistant and Associate Professor at David Geffen School of Medicine at UCLA. Currently, he serves as a Professor of Medicine at David Geffen School of Medicine at UCLA and as the Co-Director of the Gastrointestinal Oncology Program at UCLA Health.
z*********@******.ucla
(310) ***-****
Santa Monica, California
Get a FREE Demo of Dr. Zev Wainberg, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
148
Media & News
1054
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|---|---|
Ziba Hadizadehraissi, v. Keyvan Shirazi, M.D., et al. | Treating/ Examining Physician | 2016-11-28 00:00:00+00 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 148 records
Title | Type |
---|---|
Erratum: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer (PLoS ONE (2013) 8:3 (e54014) DOI: 10.1371/journal.pone.0054014) | Erratum |
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study | Journal Article |
Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review | Review |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 1054 records
Title | Description |
---|---|
UCLA Non-Hodgkin Lymphoma Clinical Trials for 2024 | Jul 17, 2024 ----- Non-Hodgkin Lymphoma clinical trials at UCLA . 54 in progress ... Zev Wainberg Sven De Vos Monica Mead Herbert Eradat James Chng. Last ... |
Positive Results For Borderline Resectable Disease Pilot ... | Jul 16, 2024 ----- Dr. Zev Wainberg provides details on a trial of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer. |
Zev A. Wainberg - Oncodaily Tag | Zev A. Wainberg . Jun 26, 2024, 14:10 | Blog Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma Maria Babak shared a post by The Babak Lab on ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
Tel Aviv University Faculty of Medicine | Doctor of Medicine |
Title | Employer |
---|---|
Professor | David Geffen School of Medicine at UCLA |
Associate Professor | David Geffen School of Medicine at UCLA |
Director | UCLA Jonsson Comprehensive Cancer Center |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.